Pulheim, Germany

Manfred Klemm

This inventor holds 1 USPTO granted patent. Top assignee: Basf Plant Science Gmbh. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manfred Klemm. Retrieved from https://idiyas.com/inventor/manfred-klemm-j3jupcgv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manfred Klemm: Inventor in Plant Biotechnology.

Introduction

Manfred Klemm is an inventor associated with Pulheim, Germany, and BASF Plant Science GmbH. His patent work concerns genetic engineering methods involving homologous recombination.

Latest Patents

The supplied information lists one patent for Klemm: “Stimulation of Homologous Recombination in Eukaryotic Organisms or Cells by Recombination Promoting Enzymes.” The invention describes a process for producing transgenic organisms or cells. It also addresses vectors containing DNA that encodes recombination-promoting enzymes, with proposed applications in addressing environmental damage in plants and plant cells and in gene therapy involving mammals or mammalian cells. The patent further concerns transgenic organisms or cells obtainable through the process and novel vectors. Klemm is credited with 1 patent.

Career Highlights

Klemm’s listed patent reflects work at the intersection of molecular biology and biotechnology, particularly the use of recombination-promoting enzymes in genetic modification. The supplied information associates him with BASF Plant Science GmbH.

Collaborations

The listed coworkers associated with Klemm are Bernd Reiss and Hans Kosak.

Conclusion

Manfred Klemm’s recorded invention focuses on promoting homologous recombination, with potential applications in transgenic organisms, plant biotechnology, and gene therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…